3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
3
Neoplasms
2
Plasmacytoma
1
Pathologic Complete Response
1
Multiple Myeloma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Large Granular Lymphocytic
1
Hepatic Insufficiency
1
Hematologic Neoplasms
1
Hematologic Diseases
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Cisplatin
32
Gemcitabine
21
Radiotherapy, Intensity-Modulated
16
toripalimab
14
Capecitabine
11
Magnetic Resonance Spectroscopy
10
Specimen Handling
9
Radiotherapy
7
Drug Therapy
7
pembrolizumab
6
Platinum
6
Nivolumab
6
Immune Checkpoint Inhibitors
6
1,2-diaminocyclohexaneplatinum II citrate
6
Docetaxel
5
tislelizumab
4
spartalizumab
4
camrelizumab
4
sintilimab
3
anlotinib
3
Immunoglobulin G
3
Disulfides
3
Carboplatin
3
nimotuzumab
2
fludarabine
2
atezolizumab
2
Taxes
2
Radiation
2
Phantoms, Imaging
2
Ipilimumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Nasopharyngeal Carcinoma
×
cc-486
×
1 year
×
Clear all
No trials found.